Home › Funds › Melqart Asset Management (UK) Ltd › INDV

Melqart Asset Management (UK) Ltd position in INDV

INDIVIOR PHARMACEUTICALS INC · Health Care

Melqart Asset Management (UK) Ltd reported holding 608,698 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$21.8M, representing 2.24% of its reported portfolio and ranking #17 among its reported holdings. Melqart Asset Management (UK) Ltd has disclosed INDV holdings in 7 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)608.70K sh
Reported value held$21.82M
Portfolio Weight2.24%
First reportedQ3 2024
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Melqart Asset Management (UK) Ltd's INDV position evolved

Melqart Asset Management (UK) Ltd first disclosed a stake in INDV in Q3 2024 at 13,510 shares (US$132K). The position peaked in Q2 2026 at 585,664 shares, worth US$24.0M. Across 7 filings, Melqart Asset Management (UK) Ltd increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 608,698 shares valued at US$21.8M — an increase of 23,034 shares quarter over quarter.. Notable position changes include a 676% increase in Q4 2024 (shares fell 23% over the following quarter), a 268% increase in Q3 2025 (shares rose 49% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 13.51K $131.72K New
Q4 2024 104.79K $1.30M Add
Q2 2025 167.54K $2.47M New
Q3 2025 616.86K $14.87M Add
Q1 2026 684.32K $20.86M New
Q2 2026 585.66K $24.03M Reduce
Q3 2026 608.70K $21.82M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INDV and 13F data

INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Madison Avenue Partners, LP (US$173.9M), Two Seas Capital LP (US$131.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INDV

All INDV fund holders →

FAQ

How long has Melqart Asset Management (UK) Ltd held INDV?

Melqart Asset Management (UK) Ltd has disclosed INDV holdings in 7 of the last 9 reported quarters, going back to Q3 2024.

What is Melqart Asset Management (UK) Ltd's current position in INDV?

As of Q3 2026, Melqart Asset Management (UK) Ltd holds 608.70K shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $21.82M, representing 2.24% of its reported portfolio and ranking #17.

Has Melqart Asset Management (UK) Ltd been buying or selling INDV?

In the latest 13F filing (Q3 2026), Melqart Asset Management (UK) Ltd increased its position in INDV. The position peaked in Q2 2026 at 585.66K shares.

Which other funds hold INDV?

Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Madison Avenue Partners, LP, Two Seas Capital LP, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.